Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance

Diabetes

Volumn 57, Issue 6, 2008, Pages 1526-1535

  Li, Ming ^a   Kim, Dong Hyun ^a   Tsenovoy, Peter L ^a   Peterson, Stephen J ^a   Rezzani, Rita ^b   Rodella, Luigi F ^b   Aronow, Wilbert S ^a   Ikehara, Susumu ^c   Abraham, Nader G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESOPORPHYRIN; PROTOPORPHYRIN COBALT; TUMOR NECROSIS FACTOR ALPHA; CARBON MONOXIDE; CYTOKINE; HEME OXYGENASE; PROTOPORPHYRIN;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BODY WEIGHT; BONE MARROW CELL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC OBESITY; FAT CONTENT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; MESENCHYMAL STEM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS FAT; UPREGULATION; WEIGHT GAIN; WESTERN BLOTTING; ADIPOCYTE; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ENZYME INDUCTION; HEART MUSCLE; HISTOLOGY; KIDNEY; METABOLISM; MOUSE MUTANT; SKIN; STEM CELL; VISCERA;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CARBON MONOXIDE; CYTOKINES; ENZYME INDUCTION; HEME OXYGENASE (DECYCLIZING); INSULIN; KIDNEY; MALE; MICE; MICE, OBESE; MYOCARDIUM; PROTOPORPHYRINS; SKIN; STEM CELLS; THINNESS; VISCERA;

EID: 41149155892     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1764     Document Type: Article

References (50)

1. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351-42354, 2004
2. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119, 2005
3. Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, Tambascia M, Bouskela E: Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 61:433-440, 2006
4. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG: D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111:3126-3134, 2005
5. Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B: Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab 9:761-763, 2007
6. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I: Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47:1108-1116, 2006
7. Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE: The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280:4617-4626, 2005
8. Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, Accili D: Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 56:1969-1976, 2007
9. Berg AH, Scherer PE: Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949, 2005
10. Kim JY, van de WE, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE: Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117:2621-2637, 2007
11. Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T: Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281:8748-8755, 2006
12. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953, 2001
13. Basu R, Pajvani UB, Rizza RA, Scherer PE: Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56:2174-2177, 2007
14. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27-e31, 2004
15. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT: Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55:249-259, 2006
16. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsu-zawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79 -83, 1999
17. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001
18. Hopkins TA, Ouchi N, Shibata R, Walsh K: Adiponectin actions in the cardiovascular system. Cardiovasc Res 74:11-18, 2007
19. Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A: Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology (Carlton) 12:147-153, 2007
20. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I: Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52:1655-1663, 2003
21. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, Leitinger N: Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 27:1276-1282, 2007
22. Abraham NG, Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127, 2008
23. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li VG, Goodman AI, Kappas A: Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287:H2468-H2477, 2004
24. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond G, McClung J, Abraham N: Beneficial effect of heme oxygenase-1 expression in myocardial ischemia- reperfusion increases adiponectin in mildly diabetic rats. Am J Phyisiol Heart Circ Physiol 293:H3532-H3541, 2007
25. Jung TW, Lee JY, Shim WS, Kang ES, Kim JS, Ahn CW, Lee HC, Cha BS: Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. Biochem Pharmacol 72:616-623, 2006
26. Peterson SJ, Drummond G, Hyun Kim D, Li M, Kruger AL, Ikehara S, Abraham NG: I-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice. J Lipid Res. 19 April 2008 [Epub ahead of print]
27. Chernick RJ, Martasek P, Levere RD, Margreiter R, Abraham NG: Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology 10:365-369, 1989
28. Kaide J-I, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, Balazy M, Abraham NG, Nasjletti A: Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107:1163-1171, 2001
29. Abraham NG, Jiang H, Balazy M, Goodman AI: Methods for measurements of heme oxygenase (HO) isoforms-mediated synthesis of carbon monoxide and HO-1 and HO-2 proteins. Methods Mol Med 86:399-411, 2003
30. Mohazzab H, Kaminski PM, Fayngersh RP, Wolin MS: Oxygen-elicited responses in calf coronary arteries: role of H2O2 production via NADH-derived superoxide. Am J Physiol H1044-H1053, 1996
31. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M, Edwards J, Wolin MS: Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 288:H13-H21, 2005
32. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L: Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23:1105-1112, 2005
33. Keating A: Mesenchymal stromal cells. Curr Opin Hematol 13:419-425, 2006
34. Segers VF, Van R, I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJ, Kockx MM, De Keulenaer GW: Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol 290:H1370-H1377, 2006
35. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, Wolin M: Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93:507-514, 2003
36. Muse ED, Lam TK, Scherer PE, Rossetti L: Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117:1670-1678, 2007
37. Lazar MA: How obesity causes diabetes: not a tall tale. Science 307:373-375, 2005
38. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, Ouchi N, Kihara S, Kawamoto T, Sumitsuji S, Funahashi T, Matsuzawa Y: Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 51:2325-2328, 2002
39. Han SH, Quon MJ, Kim JA, Koh KK: Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 49:531-538, 2007
40. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S: Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56:1010-1013, 2007
41. Iwashima Y, Horio T, Suzuki Y, Kihara S, Rakugi H, Kangawa K, Funahashi T, Ogihara T, Kawano Y: Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 188:384-390, 2006
42. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, Ito Y, Kamon J, Tsuchida A, Kumagai K, Kozono H, Hada Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Awazawa M, Takamoto I, Froguel P, Hara K, Tobe K, Nagai R, Ueki K, Kadowaki T: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13:332-339, 2007
43. Galbraith RA, Kappas A: Cobalt-protoporphyrin suppresses expression of genetic obesity in homozygous (fa/fa) Zucker rats. Pharmacology 41:292-298, 1990
44. Galbraith RA, Kappas A: Regulation of food intake and body weight in rats by the synthetic heme analogue cobalt protoporphyrin. Am J Physiol 261:R1388-R1394, 1991
45. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, Ikehara S, Wolin MS, Abraham NG: Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289:H701-H707, 2005
46. Ollinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, Csizmadia E, Usheva A, Margreiter R, Bach FH: Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 6:39-43, 2007
47. Wang ZV, Schraw TD, Kim JY, Khan T, Rajala MW, Follenzi A, Scherer PE: Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 27:3716-3731, 2007
48. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ: Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290:R601-R608, 2006
49. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF: Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148: 241-251, 2007
50. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751, 2001